Comparative Study
doi: 10.1128/AAC.40.1.212.
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae
Affiliations
- PMID: 8787907
- PMCID: PMC163084
- DOI: 10.1128/AAC.40.1.212
Item in Clipboard
Comparative Study
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae
Antimicrob Agents Chemother.
1996 Jan.
Abstract
Thirteen strains of Chlamydia pneumoniae were evaluated for their in vitro susceptibilities to azithromycin, clarithromycin, erythromycin, and tetracycline. The MIC ranges were 0.125 to 0.5 micrograms/ml for azithromycin, 0.031 to 1.0 micrograms/ml for clarithromycin, 0.125 to 1.0 micrograms/ml for erythromycin, and 0.25 to 1.0 micrograms/ml for tetracycline. The ranges for the minimal lethal concentrations were 0.125 to 0.5 micrograms/ml for azithromycin, 0.031 to 1.0 micrograms/ml for clarithromycin, 0.125 to 1.0 micrograms/ml for erythromycin, and 0.25 to 1.0 micrograms/ml for tetracycline. Clarithromycin and azithromycin were the most active antibiotics against C. pneumoniae in vitro.
Similar articles
-
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1992 Jul;36(7):1573-4. doi: 10.1128/AAC.36.7.1573. Antimicrob Agents Chemother. 1992. PMID: 1324650 Free PMC article.
-
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.Antimicrob Agents Chemother. 1996 Nov;40(11):2669-70. doi: 10.1128/AAC.40.11.2669. Antimicrob Agents Chemother. 1996. PMID: 8913488 Free PMC article.
-
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.Antimicrob Agents Chemother. 1993 Sep;37(9):1746-8. doi: 10.1128/AAC.37.9.1746. Antimicrob Agents Chemother. 1993. PMID: 8239579 Free PMC article.
-
Microbiologic activity of the newer macrolide antibiotics.Pediatr Infect Dis J. 1997 Apr;16(4):432-7. doi: 10.1097/00006454-199704000-00026. Pediatr Infect Dis J. 1997. PMID: 9109155 Review.
-
The macrolides: erythromycin, clarithromycin, and azithromycin.Mayo Clin Proc. 1999 Jun;74(6):613-34. doi: 10.4065/74.6.613. Mayo Clin Proc. 1999. PMID: 10377939 Review.
Cited by
-
Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.Paediatr Drugs. 2001;3(10):733-61. doi: 10.2165/00128072-200103100-00003. Paediatr Drugs. 2001. PMID: 11706924 Review.
-
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.Drugs. 2020 Feb;80(3):285-313. doi: 10.1007/s40265-020-01257-4. Drugs. 2020. PMID: 31970713 Review.
-
Antibacterial activity of biosecur(®) citrus extract surface cleaner against Vibrio vulnificus.Open Microbiol J. 2013 Nov 8;7:130-4. doi: 10.2174/1874285801307010130. eCollection 2013. Open Microbiol J. 2013. PMID: 24302976 Free PMC article.
-
Azithromycin. A review of its use in paediatric infectious diseases.Drugs. 1998 Aug;56(2):273-97. doi: 10.2165/00003495-199856020-00014. Drugs. 1998. PMID: 9711451 Review.
-
Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.Infection. 1999 May-Jun;27(3):198-202. doi: 10.1007/BF02561528. Infection. 1999. PMID: 10378132 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
